[(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate

C29H42O12 — CID 99575305

IUPAC[(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate
SMILESCC(=O)OC[C@@]12[C@@H]3[C@@H](CC[C@@]1(O)C[C@@H](OC(C)=O)C[C@@H]2OC(C)=O)[C@]1(O)CC[C@H](C(=O)CO)[C@@]1(C)C[C@H]3OC(C)=O
InChIInChI=1S/C29H42O12/c1-15(31)38-14-28-24(41-18(4)34)10-19(39-16(2)32)11-27(28,36)8-6-21-25(28)23(40-17(3)33)12-26(5)20(22(35)13-30)7-9-29(21,26)37/h19-21,23-25,30,36-37H,6-14H2,1-5H3/t19-,20+,21+,23+,24-,25+,26+,27+,28+,29+/m0/s1
InChIKeySSLYMDNKVJXOQX-SCDSESHRSA-N
MW582.64 g/mol
LogP0.99
Rot. Bonds7

About [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate

[(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate (PubChem CID 99575305) has the molecular formula C29H42O12 and a molecular weight of 582.64 g/mol. Its IUPAC name is [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate.

Molecular Properties

Compound Name[(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate
PubChem CID99575305
Molecular FormulaC29H42O12
Molecular Weight582.64 g/mol
Exact Mass582.27
IUPAC Name[(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate
SMILESCC(=O)OC[C@@]12[C@@H]3[C@@H](CC[C@@]1(O)C[C@@H](OC(C)=O)C[C@@H]2OC(C)=O)[C@]1(O)CC[C@H](C(=O)CO)[C@@]1(C)C[C@H]3OC(C)=O
InChIInChI=1S/C29H42O12/c1-15(31)38-14-28-24(41-18(4)34)10-19(39-16(2)32)11-27(28,36)8-6-21-25(28)23(40-17(3)33)12-26(5)20(22(35)13-30)7-9-29(21,26)37/h19-21,23-25,30,36-37H,6-14H2,1-5H3/t19-,20+,21+,23+,24-,25+,26+,27+,28+,29+/m0/s1
InChIKeySSLYMDNKVJXOQX-SCDSESHRSA-N
XLogP0.99
TPSA182.96 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds7
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500582.64
LogP ≤ 50.99
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}

Analyze [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate?
The IUPAC name of [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate (CID 99575305) is [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate.
What is the SMILES notation for [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate?
The canonical SMILES for [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate is CC(=O)OC[C@@]12[C@@H]3[C@@H](CC[C@@]1(O)C[C@@H](OC(C)=O)C[C@@H]2OC(C)=O)[C@]1(O)CC[C@H](C(=O)CO)[C@@]1(C)C[C@H]3OC(C)=O.
What is the InChIKey of [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate?
The InChIKey is SSLYMDNKVJXOQX-SCDSESHRSA-N. The full InChI is InChI=1S/C29H42O12/c1-15(31)38-14-28-24(41-18(4)34)10-19(39-16(2)32)11-27(28,36)8-6-21-25(28)23(40-17(3)33)12-26(5)20(22(35)13-30)7-9-29(21,26)37/h19-21,23-25,30,36-37H,6-14H2,1-5H3/t19-,20+,21+,23+,24-,25+,26+,27+,28+,29+/m0/s1.
What are the key properties of [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate?
[(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate has a molecular weight of 582.64 g/mol, XLogP of 0.99, 7 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,3S,5R,8R,9S,10R,11R,13R,14R,17S)-1,3,11-triacetyloxy-5,14-dihydroxy-17-(2-hydroxyacetyl)-13-methyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-10-yl]methyl acetate is sourced from PubChem (CID 99575305), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).